Gardiner Healthcare Acquisitions Corp. (the “Company”) announced today that it intends to deposit, or have deposited, into the Company’s trust account the amount of $100,000 in order to extend the…
Sonendo, Inc. (NYSE: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today announced that, on November 15, 2023, it received a notice…
RootPath announced today the US launch of its flagship product, RootPath Custom Gene Library. Similar to conventional gene synthesis products, this product is delivered as individual, sequence-verified plasmids in 96-…
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), today announced The Lancet Neurology published online preliminary results of a clinical trial conducted by Astellas Pharma using…
Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has successfully completed the world’s first-in-human case utilizing its newest donor lung preservation technology, the BAROguard™ Donor Lung…
Avistone Announces the First Approval of Vebreltinib for MET Exon 14 Skipping Non-Small Cell Lung Cancer Opening a New Chapter in MET-targeted Treatment of Lung Cancer Avistone Biotechnology Co. Ltd.…
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced…
SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed…
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders…
BeautyHealth Announces Leadership Transition The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that Andrew Stanleick will depart the Company as President & Chief Executive Officer and…
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that…
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced third…